122 related articles for article (PubMed ID: 10346923)
1. Solution conformation of a potent cyclic analogue of tuftsin: low- temperature nuclear magnetic resonance study in a cryoprotective mixture.
D'Ursi A; Albrizio S; Fattorusso C; Lavecchia A; Zanotti G; Temussi PA
J Med Chem; 1999 May; 42(10):1705-13. PubMed ID: 10346923
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
[TBL] [Abstract][Full Text] [Related]
3. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
4. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
[TBL] [Abstract][Full Text] [Related]
5. Simulations of conformers of tuftsin and a cyclic tuftsin analog.
Valdeavella CV; Blatt HD; Pettitt BM
Int J Pept Protein Res; 1995 Nov; 46(5):372-80. PubMed ID: 8567181
[TBL] [Abstract][Full Text] [Related]
6. Analysis of conformational equilibria in aplidine using selective excitation 2D NMR spectroscopy and molecular mechanics/dynamics calculations.
Cárdenas F; Caba JM; Feliz M; Lloyd-Williams P; Giralt E
J Org Chem; 2003 Dec; 68(25):9554-62. PubMed ID: 14656079
[TBL] [Abstract][Full Text] [Related]
7. Quenched molecular dynamics simulations of tuftsin and proposed cyclic analogues.
O'Connor SD; Smith PE; al-Obeidi F; Pettitt BM
J Med Chem; 1992 Jul; 35(15):2870-81. PubMed ID: 1495018
[TBL] [Abstract][Full Text] [Related]
8. Solution conformation of tuftsin.
D'Ursi A; Pegna M; Amodeo P; Molinari H; Verdini A; Zetta L; Temussi PA
Biochemistry; 1992 Oct; 31(40):9581-6. PubMed ID: 1327119
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of cyclic kallidin analogues in DMSO by nuclear magnetic resonance and molecular dynamics.
Schievano E; Silvestri L; Gobbo M; Mammi S; Rocchi R; Peggion E
J Pept Sci; 2005 Jan; 11(1):3-16. PubMed ID: 15635722
[TBL] [Abstract][Full Text] [Related]
10. The cyclic contryphan motif CPxXPXC, a robust scaffold potentially useful as an omega-conotoxin mimic.
Pallaghy PK; Norton RS
Biopolymers; 2000 Sep; 54(3):173-9. PubMed ID: 10861378
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
[TBL] [Abstract][Full Text] [Related]
12. On the transferability of atomic solvation parameters: Ab initio structural prediction of cyclic heptapeptides in DMSO.
Baysal C; Meirovitch H
Biopolymers; 2000 Nov; 54(6):416-28. PubMed ID: 10951328
[TBL] [Abstract][Full Text] [Related]
13. Beta2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds.
Norgren AS; Büttner F; Prabpai S; Kongsaeree P; Arvidsson PI
J Org Chem; 2006 Sep; 71(18):6814-21. PubMed ID: 16930031
[TBL] [Abstract][Full Text] [Related]
14. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
16. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
[TBL] [Abstract][Full Text] [Related]
17. Conformational mobility in cyclic oligopeptides.
Kopple KD; Bean JW; Bhandary KK; Briand J; D'Ambrosio CA; Peishoff CE
Biopolymers; 1993 Jul; 33(7):1093-9. PubMed ID: 8102073
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study of conformational flexibility of tuftsin in vacuum and in aqueous environment.
Kothekar V; Ashish ; Gupta D; Kishore R
Indian J Biochem Biophys; 1999 Feb; 36(1):14-28. PubMed ID: 10549156
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
[TBL] [Abstract][Full Text] [Related]
20. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
